3012 related articles for article (PubMed ID: 27542004)
21. Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology.
Sheikine Y; Kuo FC; Lindeman NI
J Clin Oncol; 2017 Mar; 35(9):929-933. PubMed ID: 28297627
[TBL] [Abstract][Full Text] [Related]
22. Next generation sequencing: implications in personalized medicine and pharmacogenomics.
Rabbani B; Nakaoka H; Akhondzadeh S; Tekin M; Mahdieh N
Mol Biosyst; 2016 May; 12(6):1818-30. PubMed ID: 27066891
[TBL] [Abstract][Full Text] [Related]
23. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
[TBL] [Abstract][Full Text] [Related]
24. A new generation of cancer genome diagnostics for routine clinical use: overcoming the roadblocks to personalized cancer medicine.
Heuckmann JM; Thomas RK
Ann Oncol; 2015 Sep; 26(9):1830-1837. PubMed ID: 25899787
[TBL] [Abstract][Full Text] [Related]
25. The pathway to clinical use of a cancer biomarker.
Henry NL
Scand J Clin Lab Invest Suppl; 2016; 245():S17-21. PubMed ID: 27410238
[TBL] [Abstract][Full Text] [Related]
26. Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.
Morganti S; Tarantino P; Ferraro E; D'Amico P; Viale G; Trapani D; Duso BA; Curigliano G
Crit Rev Oncol Hematol; 2019 Jan; 133():171-182. PubMed ID: 30661654
[TBL] [Abstract][Full Text] [Related]
27. Cancer Precision Medicine: Why More Is More and DNA Is Not Enough.
Schütte M; Ogilvie LA; Rieke DT; Lange BMH; Yaspo ML; Lehrach H
Public Health Genomics; 2017; 20(2):70-80. PubMed ID: 28595192
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.
Hovelson DH; McDaniel AS; Cani AK; Johnson B; Rhodes K; Williams PD; Bandla S; Bien G; Choppa P; Hyland F; Gottimukkala R; Liu G; Manivannan M; Schageman J; Ballesteros-Villagrana E; Grasso CS; Quist MJ; Yadati V; Amin A; Siddiqui J; Betz BL; Knudsen KE; Cooney KA; Feng FY; Roh MH; Nelson PS; Liu CJ; Beer DG; Wyngaard P; Chinnaiyan AM; Sadis S; Rhodes DR; Tomlins SA
Neoplasia; 2015 Apr; 17(4):385-99. PubMed ID: 25925381
[TBL] [Abstract][Full Text] [Related]
29. Clinical Utility of Circulating Tumor DNA for Molecular Assessment and Precision Medicine in Pancreatic Cancer.
Takai E; Totoki Y; Nakamura H; Kato M; Shibata T; Yachida S
Adv Exp Med Biol; 2016; 924():13-17. PubMed ID: 27753011
[TBL] [Abstract][Full Text] [Related]
30. Next-generation sequencing and its applications in molecular diagnostics.
Su Z; Ning B; Fang H; Hong H; Perkins R; Tong W; Shi L
Expert Rev Mol Diagn; 2011 Apr; 11(3):333-43. PubMed ID: 21463242
[TBL] [Abstract][Full Text] [Related]
31. Next-generation sequencing in the clinic: promises and challenges.
Xuan J; Yu Y; Qing T; Guo L; Shi L
Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
[TBL] [Abstract][Full Text] [Related]
32. Microarray and next-generation sequencing to analyse gastric cancer.
Dang Y; Wang YC; Huang QJ
Asian Pac J Cancer Prev; 2014; 15(19):8033-9. PubMed ID: 25338980
[TBL] [Abstract][Full Text] [Related]
33. Colorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm.
Furtado LV; Samowitz WS
Virchows Arch; 2017 Aug; 471(2):235-242. PubMed ID: 28551725
[TBL] [Abstract][Full Text] [Related]
34. Transcriptomics in cancer diagnostics: developments in technology, clinical research and commercialization.
Sager M; Yeat NC; Pajaro-Van der Stadt S; Lin C; Ren Q; Lin J
Expert Rev Mol Diagn; 2015; 15(12):1589-603. PubMed ID: 26565429
[TBL] [Abstract][Full Text] [Related]
35. Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial.
Stockley TL; Oza AM; Berman HK; Leighl NB; Knox JJ; Shepherd FA; Chen EX; Krzyzanowska MK; Dhani N; Joshua AM; Tsao MS; Serra S; Clarke B; Roehrl MH; Zhang T; Sukhai MA; Califaretti N; Trinkaus M; Shaw P; van der Kwast T; Wang L; Virtanen C; Kim RH; Razak AR; Hansen AR; Yu C; Pugh TJ; Kamel-Reid S; Siu LL; Bedard PL
Genome Med; 2016 Oct; 8(1):109. PubMed ID: 27782854
[TBL] [Abstract][Full Text] [Related]
36. Validation of the Oncomine
Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
[TBL] [Abstract][Full Text] [Related]
37. Understanding next generation sequencing in oncology: A guide for oncologists.
Moorcraft SY; Gonzalez D; Walker BA
Crit Rev Oncol Hematol; 2015 Dec; 96(3):463-74. PubMed ID: 26160606
[TBL] [Abstract][Full Text] [Related]
38. Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes.
Donovan MJ; Cordon-Cardo C
Mol Diagn Ther; 2017 Apr; 21(2):115-123. PubMed ID: 28000172
[TBL] [Abstract][Full Text] [Related]
39. Using circulating cell-free DNA to monitor personalized cancer therapy.
Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.
Cronin M; Ross JS
Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
